(Philadelphia,
PA) - Jeanne M. Manson, PhD, MSCE, has joined
the Department of Pediatrics at the University of Pennsylvania
School of Medicine, as an Associate Professor. She is
also a Research Scientist in the Division of Human Genetics
& Molecular Biology at The Children's Hospital of
Philadelphia.
Dr. Manson's area of research is molecular epidemiology
of birth defects, specifically gene-environment interaction
in the causation of developmental defects. She has been
published in the peer-reviewed publications, Developmental
Biology, Teratology, Toxicology, the Journal
of Embryological Experimental Morphology and Environmental
Research.
Dr. Manson earned her BA in Biology and Chemistry from
Emmanuel College in Boston. She went on to receive her
PhD in Developmental Biology from Ohio State University
and her Master of Science in Clinical Epidemiology (MSCE)
from the University of Pennsylvania. Prior to her appointment
at the University of Pennsylvania School of Medicine,
she was a Research Professor in the Department of Obstetrics
and Gynecology at Thomas Jefferson University in Philadelphia.
Among her many awards, honors and memberships, Dr. Manson
has received a Scientific Achievement Award from the
Society of Toxicology and is a diplomate in General
Toxicology appointed by the Academy of Toxicological
Sciences. She serves as a consultant to the Federal
Drug Administration (FDA) on labeling of drugs for use
in pregnancy and pregnancy registries and as a consultant
to the American Chemistry Council's Endocrine Technical
Implementation panel. Dr. Manson is also an Associate
Editor for the publication, Birth Defects Research.
# # #
.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.
The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.